Size and surface charge of gold nanoparticles determine absorption across intestinal barriers and accumulation in secondary target organs after oral administration

References

• Aggarwal P, Hall JB, McLeland CB, Dobrovolskaia MA, McNeil SE. 2009. Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy. Adv Drug Deliv Rev 61(6):428–437.
   PubMed Web of Science ®Google Scholar
• Asuri P, Karajanagi SS, Yang H, Yim TJ, Kane RS, Dordick JS. 2006. Increasing protein stability through control of the nanoscale environment. Langmuir 22(13):5833–5836.
   PubMed Web of Science ®Google Scholar
• Balasubramanian R, Guo R, Mills AJ, Murray RW. 2005. Reaction of Au(55)(PPh(3))(12)Cl(6) with thiols yields thiolate monolayer protected Au(75) clusters. J Am Chem Soc 127(22):8126–8132.
   PubMed Web of Science ®Google Scholar
• Bhardwaj V, Ankola DD, Gupta SC, Schneider M, Lehr CM, Kumar MN. 2009. PLGA nanoparticles stabilized with cationic surfactant: Safety studies and application in oral delivery of paclitaxel to treat chemical-induced breast cancer in rat. Pharm Res 26(11):2495–2503.
   PubMed Web of Science ®Google Scholar
• Cartiera MS, Johnson KM, Rajendran V, Caplan MJ, Saltzman WM. 2009. The uptake and intracellular fate of PLGA nanoparticles in epithelial cells. Biomaterials 30(14):2790–2798.
   PubMed Web of Science ®Google Scholar
• Cho M, Cho WS, Choi M, Kim SJ, Han BS, Kim SH, Kim HO, Sheen YY, Jeong J. 2009. The impact of size on tissue distribution and elimination by single intravenous injection of silica nanoparticles. Toxicol Lett 189(3):177–183.
   PubMed Web of Science ®Google Scholar
• Connor EE, Mwamuka J, Gole A, Murphy CJ, Wyatt MD. 2005. Gold nanoparticles are taken up by human cells but do not cause acute cytotoxicity. Small 1(3):325–327.
   PubMed Web of Science ®Google Scholar
• des Rieux A, Fievez V, Garinot M, Schneider YJ, Preat V. 2006. Nanoparticles as potential oral delivery systems of proteins and vaccines: A mechanistic approach. J Control Release 116(1):1–27.
   PubMed Web of Science ®Google Scholar
• des Rieux A, Ragnarsson EG, Gullberg E, Preat V, Schneider YJ, Artursson P. 2005. Transport of nanoparticles across an in vitro model of the human intestinal follicle associated epithelium. Eur J Pharm Sci 25(4–5):455–465.
   PubMed Web of Science ®Google Scholar
• Dobrovolskaia MA, Patri AK, Zheng J, Clogston JD, Ayub N, Aggarwal P, Neun BW, Hall JB, McNeil SE. 2009. Interaction of colloidal gold nanoparticles with human blood: Effects on particle size and analysis of plasma protein binding profiles. Nanomedicine 5(2):106–117.
   PubMed Web of Science ®Google Scholar
• Doyle-McCullough M, Smyth SH, Moyes SM, Carr KE. 2007. Factors influencing intestinal microparticle uptake in vivo. Int J Pharm 335(1–2):79–89.
   PubMedGoogle Scholar
• Florence AT, Hillery AM, Hussain N, Jani PU. 1995. Factors affecting the oral uptake and translocation of polystyrene nanoparticles: Histological and analytical evidence. J Drug Target 3(1):65–70.
   PubMed Web of Science ®Google Scholar
• Florence AT. 2007. Pharmaceutical nanotechnology: More than size. Ten topics for research. Int J Pharm 339(1–2):1–2.
   PubMedGoogle Scholar
• Florence AT, Sakthivel T, Toth I. 2000. Oral uptake and translocation of a polylysine dendrimer with a lipid surface. J Control Release 65(1–2):253–259.
   PubMed Web of Science ®Google Scholar
• Gebert A, Rothkotter HJ, Pabst R. 1996. M cells in Peyer's patches of the intestine. Int Rev Cytol 167:91–159.
   PubMed Web of Science ®Google Scholar
• Geiser M, Rothen-Rutishauser B, Kapp N, Schurch S, Kreyling W, Schulz H, Semmler M, Im HV, Heyder J, Gehr P. 2005. Ultrafine particles cross cellular membranes by nonphagocytic mechanisms in lungs and in cultured cells. Environ Health Perspect 113(11):1555–1560.
   PubMed Web of Science ®Google Scholar
• Hariharan S, Bhardwaj V, Bala I, Sitterberg J, Bakowsky U, Ravi Kumar MN. 2006. Design of estradiol loaded PLGA nanoparticulate formulations: A potential oral delivery system for hormone therapy. Pharm Res 23(1):184–195.
   PubMed Web of Science ®Google Scholar
• He C, Hu Y, Yin L, Tang C, Yin C. 2010. Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles. Biomaterials 31(13):3657–3666.
   PubMed Web of Science ®Google Scholar
• Hillery AM, Jani PU, Florence AT. 1994. Comparative, quantitative study of lymphoid and non-lymphoid uptake of 60 nm polystyrene particles. J Drug Target 2(2):151–156.
   PubMed Web of Science ®Google Scholar
• Hillyer JF, Albrecht RM. 2001. Gastrointestinal persorption and tissue distribution of differently sized colloidal gold nanoparticles. J Pharm Sci 90(12):1927–1936.
   PubMed Web of Science ®Google Scholar
• Hirn S, Semmler-Behnke M, Schleh C, Wenk A, Lipka J, Schäffler M, Takenaka S, Möller W, Schmid G, Simon U, Kreyling WG. Particle size-dependent and surface charge-dependent biodistribution of gold nanoparticles after intravenous administration. Eur J Pharm Biopharm. 2010 Dec 31. [Epub ahead of print]
   PubMed Web of Science ®Google Scholar
• Hussain N, Florence AT. 1998. Utilizing bacterial mechanisms of epithelial cell entry: Invasin-induced oral uptake of latex nanoparticles. Pharm Res 15(1):153–156.
   PubMed Web of Science ®Google Scholar
• Jani P, Halbert GW, Langridge J, Florence AT. 1990. Nanoparticle uptake by the rat gastrointestinal mucosa: Quantitation and particle size dependency. J Pharm Pharmacol 42(12):821–826.
   PubMed Web of Science ®Google Scholar
• Jani P, Halbert GW, Langridge J, Florence AT. 1989. The uptake and translocation of latex nanospheres and microspheres after oral administration to rats. J Pharm Pharmacol 41(12):809–812.
   PubMed Web of Science ®Google Scholar
• Jani PU, Nomura T, Yamashita F, Takakura Y, Florence AT, Hashida M. 1996. Biliary excretion of polystyrene microspheres with covalently linked FITC fluorescence after oral and parenteral administration to male Wistar rats. J Drug Target 4(2):87–93.
   PubMed Web of Science ®Google Scholar
• Kuo CT, Yu JY, Huang MJ, Chen CH. 2010. On the size evolution of gold-monolayer-protected clusters by ligand place-exchange reactions: the effect of headgroup-gold interactions. Langmuir 26(9):6149–6153.
   PubMed Web of Science ®Google Scholar
• Lacerda SH, Park JJ, Meuse C, Pristinski D, Becker ML, Karim A, Douglas JF. 2010. Interaction of gold nanoparticles with common human blood proteins. ACS Nano 4(1):365–379.
   PubMed Web of Science ®Google Scholar
• Lundqvist M, Stigler J, Elia G, Lynch I, Cedervall T, Dawson KA. 2008. Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts. Proc Natl Acad Sci USA 105(38):14265–14270.
   PubMed Web of Science ®Google Scholar
• Lundqvist M, Sethson I, Jonsson BH. 2004. Protein adsorption onto silica nanoparticles: Conformational changes depend on the particles' curvature and the protein stability. Langmuir 20(24):10639–10647.
   PubMed Web of Science ®Google Scholar
• Nassimi M, Schleh C, Lauenstein HD, Hussein R, Hoymann HG, Koch W, Pohlmann G, Krug N, Sewald K, Rittinghausen S, Braun A, Muller-Goymann C. 2010. A toxicological evaluation of inhaled solid lipid nanoparticles used as a potential drug delivery system for the lung. Eur J Pharm Biopharm 75(2):107–116.
   Google Scholar
• Nassimi M, Schleh C, Lauenstein HD, Hussein R, Lubbers K, Pohlmann G, Switalla S, Sewald K, Muller M, Krug N, Muller-Goymann CC, Braun A. 2009. Low cytotoxicity of solid lipid nanoparticles in in vitro and ex vivo lung models. Inhal Toxicol 21(S1):104–109.
   PubMedGoogle Scholar
• Oeff K, Konig A. 1955. Das Blutvolumen einiger Rattenorgane und ihre Restblutmenge nach entbluten bzw. durchspülung - Bestimmung mit P-32-markierten Erythrocyten. Naunyn-Schmiedebergs Archiv Fur Experimentelle Pathologie Und Pharmakologi 226(1):98–102.
   PubMedGoogle Scholar
• Pan Y, Leifert A, Ruau D, Neuss S, Bornemann J, Schmid G, Brandau W, Simon U, Jahnen-Dechent W. 2009. Gold nanoparticles of diameter 1.4 nm trigger necrosis by oxidative stress and mitochondrial damage. Small 5(18):2067–2076.
   PubMed Web of Science ®Google Scholar
• Pan Y, Neuss S, Leifert A, Fischler M, Wen F, Simon U, Schmid G, Brandau W, Jahnen-Dechent W. 2007. Size-dependent cytotoxicity of gold nanoparticles. Small 3(11):1941–1949.
   PubMed Web of Science ®Google Scholar
• Potten CS, Loeffler M. 1990. Stem cells: Attributes, cycles, spirals, pitfalls and uncertainties. Lessons for and from the crypt. Development 110(4):1001–1020.
   PubMed Web of Science ®Google Scholar
• Powell JJ, Faria N, Thomas-McKay E, Pele LC. 2010. Origin and fate of dietary nanoparticles and microparticles in the gastrointestinal tract. J Autoimmun 34(3):J226–233.
   PubMed Web of Science ®Google Scholar
• Rimoldi M, Rescigno M. 2005. Uptake and presentation of orally administered antigens. Vaccine 23(15):1793–1796.
   PubMed Web of Science ®Google Scholar
• Ruenraroengsak P, Cook JM, Florence AT. 2010. Nanosystem drug targeting: Facing up to complex realities. J Control Release 141(3):265–276.
   PubMed Web of Science ®Google Scholar
• Samstein RM, Perica K, Balderrama F, Look M, Fahmy TM. 2008. The use of deoxycholic acid to enhance the oral bioavailability of biodegradable nanoparticles. Biomaterials 29(6):703–708.
   PubMed Web of Science ®Google Scholar
• Sass W, Dreyer HP, Seifert J. 1990. Rapid insorption of small particles in the gut. Am J Gastroenterol 85(3):255–260.
   PubMed Web of Science ®Google Scholar
• Schmid G. 2008. The relevance of shape and size of Au55 clusters. Chem Soc Rev 37(9):1909–1930.
   PubMed Web of Science ®Google Scholar
• Seifert J, Sass W. 1990. Intestinal absorption of macromolecules and small particles. Dig Dis 8(3):169–178.
   PubMed Web of Science ®Google Scholar
• Seifert J, Haraszti B, Sass W. 1996. The influence of age and particle number on absorption of polystyrene particles from the rat gut. J Anat 189(Pt 3):483–486.
   PubMedGoogle Scholar
• Semmler-Behnke M, Kreyling WG, Lipka J, Fertsch S, Wenk A, Takenaka S, Schmid G, Brandau W. 2008. Biodistribution of 1.4- and 18-nm gold particles in rats. Small 4(12):2108–2111.
   PubMed Web of Science ®Google Scholar
• Shang W, Nuffer JH, Muniz-Papandrea VA, Colon W, Siegel RW, Dordick JS. 2009. Cytochrome C on silica nanoparticles: Influence of nanoparticle size on protein structure, stability, and activity. Small 5(4):470–476.
   PubMed Web of Science ®Google Scholar
• Smyth SH, Feldhaus S, Schumacher U, Carr KE. 2008. Uptake of inert microparticles in normal and immune deficient mice. Int J Pharm 346(1–2):109–118.
   PubMedGoogle Scholar
• Sonavane G, Tomoda K, Sano A, Ohshima H, Terada H, Makino K. 2008. In vitro permeation of gold nanoparticles through rat skin and rat intestine: Effect of particle size. Colloids Surf B Biointerfaces 65(1):1–10.
   PubMed Web of Science ®Google Scholar
• Sperling RA, Rivera Gil P, Zhang F, Zanella M, Parak WJ. 2008. Biological applications of gold nanoparticles. Chem Soc Rev 37(9):1896–1908.
   PubMed Web of Science ®Google Scholar
• Tominaga T, Tenma S, Watanabe H, Giebel U, Schmid G. 1996. Tracer diffusion of a ligand-stabilized two-shell gold cluster. Chem Lett (12):1033–1034.
   Google Scholar
• Torjman MC, Joseph JI, Munsick C, Morishita M, Grunwald Z. 2005. Effects of isoflurane on gastrointestinal motility after brief exposure in rats. Int J Pharm 294(1–2):65–71.
   PubMedGoogle Scholar
• Vertegel AA, Siegel RW, Dordick JS. 2004. Silica nanoparticle size influences the structure and enzymatic activity of adsorbed lysozyme. Langmuir 20(16):6800–6807.
   PubMed Web of Science ®Google Scholar
• Walczyk D, Bombelli FB, Monopoli MP, Lynch I, Dawson KA. 2010. What the cell ‘sees’ in bionanoscience. J Am Chem Soc 132(16):5761–5768.
   PubMed Web of Science ®Google Scholar